AGAP2‐AS1 facilitates the occurrence and progression of certain tumors, including intrahepatic cholangiocarcinoma, breast cancer, and lung cancer, and its upregulation is linked to a poor prognosis.38, 39, 40. Here, AGAP2 is linked to lung carcinoma.